Skip to main content
SpringerLink
Log in

Das Magenkarzinom – die enge Kooperation von Forschung und Praxis verbessert die Patientenversorgung

Interview mit Prof. Dr. med. Florian Lordick, Direktor des Universitären Krebszentrums Leipzig (UCCL) sowie der Klinik für Onkologie, Gastroenterologie, Hepatologie und Pneumologie

  • Interview
  • Published:
best practice onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Shitara K, Lordick F et al (2023) Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial. Lancet 401(10389):1655–1668

    Article  CAS  PubMed  Google Scholar 

  2. Lordick F et al (2022) Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 33(10):1005–1020

    Article  CAS  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Das Magenkarzinom – die enge Kooperation von Forschung und Praxis verbessert die Patientenversorgung. best practice onkologie 18, 322–327 (2023). https://doi.org/10.1007/s11654-023-00504-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11654-023-00504-w

Search

Navigation